Anika Therapeutics (ANIK) Current Deferred Tax Assets (2010 - 2015)

Anika Therapeutics (ANIK) has reported Current Deferred Tax Assets for 6 consecutive years, with $1.4 million the latest figure, recorded in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 113.85% year-over-year to $1.4 million in Q3 2015; TTM through Sep 2015 was $1.4 million, a 113.85% increase from a year earlier, with the FY2014 full-year figure at $1.2 million, up 80.38% from the prior year.
• Current Deferred Tax Assets was $1.4 million for Q3 2015 at Anika Therapeutics, down from $1.5 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $2.0 million in Q4 2012 and troughed at $659040.0 in Q4 2013.
• A 5-year average of $1.5 million and a median of $1.9 million in 2011 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets tumbled 67.56% in 2013 and soared 125.76% in 2015, its largest moves.
• Over 5 years, Current Deferred Tax Assets stood at $1.9 million in 2011, then climbed by 5.87% to $2.0 million in 2012, then plunged by 67.56% to $659040.0 in 2013, then jumped by 80.38% to $1.2 million in 2014, then increased by 18.55% to $1.4 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $1.4 million (Q3 2015), $1.5 million (Q2 2015), and $1.5 million (Q1 2015), per Business Quant data.